Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>
Xin Yang(National Institutes of Health), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Karin Kast(University Hospital Carl Gustav Carus), Laurent Castéra(Inserm), Lisa Golmard(Université Paris Sciences et Lettres), Judy E. Garber(Dana-Farber Cancer Institute), Ian Jacobs(Children's Hospital of Philadelphia), Allan Jensen(Danish Cancer Society), Jill S. Dolinsky(Ambry Genetics (United States)), Helen Hanson(University of Exeter), Fergus J. Couch(Mayo Clinic), Holly LaDuca(Ambry Genetics (United States)), Honglin Song(University of Cambridge), Goska Leslie(University of Cambridge), Richard S. Houlston(Institute of Cancer Research), Clare Turnbull(Institute of Cancer Research), David D.L. Bowtell(The University of Melbourne), Thomas van Overeem Hansen(University of Copenhagen), Hans Ehrencrona(Lund University), Ana Vega(Complejo Hospitalario Universitario de Santiago), Joe Dennis(University of Cambridge), Estrid Høgdall(University of Copenhagen), Bernd Auber(Medizinische Hochschule Hannover), Adam N. Rosenthal(University College London), Christoph Engel(University Hospital Leipzig), Åke Borg(Lund University), Susanne K. Kjær(Copenhagen University Hospital), Malene Djursby(Copenhagen University Hospital), Ana Osório(Spanish National Cancer Research Centre), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Liisa M. Pelttari(University of Helsinki), Simon A. Gayther(The University of Texas Health Science Center at Houston), Susan J. Ramus(Cancer Institute of New South Wales), Ed Dicks(Institute of Cancer Research), Heli Nevanlinna(University of Helsinki), Ramūnas Janavičius(Vilnius University), Anders Kvist(Lund University), Eric Hahnen(University Hospital Cologne), Dieter Niederacher(Heinrich Heine University Düsseldorf), Chey Loveday(Institute of Cancer Research), Usha Menon(University of South Florida), Bárbara Rivera(Jewish General Hospital), Judith Balmañà(Vall d'Hebron Hospital Universitari), Andrew Lee(University of Cambridge), Judit Horváth(University Hospital Münster), Stephen B. Gruber(University of Michigan), Kristiina Aittomäki(University of Helsinki), Nadia Traficante(The University of Melbourne), kConFab Investigators, Orland Dı́ez(Vall d'Hebron Hospital Universitari)
Cited by 163
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k